Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 56 | 51 | −5 |
| Shares | 5.16M | 5.26M | +103.8K (+2.0%) |
| Value | $11.9M | $15.4M | +$3.45M (+29.0%) |
New holders (8)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 23,165 | $68.0K | 0.01% |
| Dimensional Fund Advisors LP | 20,696 | $60.4K | 0.00% |
| Savvy Advisors, Inc. | 18,810 | $54.9K | 0.03% |
| Assenagon Asset Management S.A. | 18,659 | $54.5K | 0.00% |
| Sage Capital Management, LLC | 16,750 | $48.9K | 0.03% |
| Mariner, LLC | 10,544 | $30.8K | 0.00% |
| Journey Strategic Wealth LLC | 10,448 | $30.5K | 0.00% |
| Steward Partners Investment Advisory, LLC | 8,826 | $25.8K | 0.00% |
Sold out (13)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 31,347 | $72.4K |
| XTX Topco Ltd | 17,325 | $40.0K |
| Algert Global LLC | 14,680 | $33.9K |
| HRT Financial LP | 11,165 | $25.0K |
| Royal Bank of Canada | 9,244 | $21.0K |
| AJOVista, LLC | 8,390 | $19.4K |
| Bourgeon Capital Management LLC | 5,627 | $13.0K |
| LM Advisors LLC | 2,500 | $5.78K |
| Quantbot Technologies LP | 2,300 | $5.31K |
| FMR LLC | 900 | $2.08K |
| Federated Hermes, Inc. | 369 | $852 |
| Brown Brothers Harriman & Co | 8 | $18 |
| BNP Paribas Arbitrage, SA | 2 | $5 |